Get Instant Summarized Text (Gist) A new drug, JRT, derived from LSD, shows promise for treating schizophrenia by promoting neuroplasticity without causing hallucinations. By altering two atoms in ...

A novel schizophrenia treatment shows promising efficacy and safety, targeting specific pathways for symptom management. Clinical trials reveal significant improvements in symptom control and ...

Having a plethora of relatively undifferentiated services no longer suffices, as many of these services can be replicated with ease. For instance, popular AWS services like S3, RDS, and EC2 have ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

Smoking cannabis affects brain chemistry so seriously it can trigger schizophrenia, scientists warn today. Researchers have found the first evidence that marijuana can cause genetic abnormalities ...

Apr. 15, 2025 — The smallest control system of vision in mammals has been mapped -- a discovery that opens entirely new insights into how our vision works and how it can be affected by ..

were expected to provide better effectiveness and promote adherence in patients with schizophrenia. This study was implemented to assess the efficacy and safety of once-daily quetiapine XR in ...

Apr. 8, 2025 — When faced with a potential threat, mice often freeze in place. Moreover, when two animals are together, they typically freeze at the same time, matching each other's periods of ...

Scientific literature has shown that patients with multiple sclerosis and schizophrenia lose myelin (called demyelination), leaving part of the axons "unplugged" and causing damage to brain function.

JRT exhibited powerful neuroplastic effects and improved measures in mice relevant to the negative and cognitive symptoms of schizophrenia, without exacerbating behaviors and gene expression ...